Skip to content. | Skip to navigation

Personal tools
Log in


You are here: Home / Projects


Active Projects

An image from the InCell Analyzer showing the Autophagy LC3 protein in GFP and DAPI in blue.

Autophagy and Apoptosis Crosstalk

Exploring the regulatory relationships between autophagy and apoptosis utilizing genetic, genomic, molecular and proteomic approaches in Drosophila and mammalian model systems.

nucleosome structure. Source:

Centre for Epigenome Mapping Technologies (CEMT)

Generating reference epigenomes for normal and malignant human cells

Colorectal Cancer Screening

This program's focus is to develop novel easy-to-administer tests that identify individuals at the earliest, most curable stages of the disease

Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT)

Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT)

Using massively parallel DNA sequencing to identify leukemia stem cell specific expression signatures, predictive of drug treatment response

Development of Technologies for the Derivation, Propagation and Differentiation of hESC

To lay the groundwork for developing human embryonic stem cell-based therapies and facilitate the broader use of these cells to identify new drugs that stimulate or repress particular regenerative events in vivo.

Device for screening the effect of thousands of compounds on prostate cancer cell cultures.

Discovery of new drug candidates for the clinical management of prostate cancer

Our aim is to identify small molecules that may prevent or delay the progression of prostate cancer towards androgen-independent disease.

Genetic Analyses of Lymphoid Neoplasms

We are applying our Illumina sequencing and bioinformatics pipelines to the genome-wide analysis of lymphomas. This will allow the identification of all of the genes being expressed by the lymphoid cells, the presence of mutated genes and chromosome rearrangements, as well as enabling the recognition of proteins which could be targetted by anti-cancer treatments.

Diagram showing the cross section of a human heart (Getty Images)

Genetics of Aortic Valve Stenosis

Aortic valve stenosis is the third leading cause of adult heart disease and the most common form of acquired heart valve disease in developed countries. Although some risk factors are known, the true interactions are complex and involve age, lifestyle factors, and genetics.

Genetics of Non-Hodgkin Lymphoma

The focus of this research is to discover the inherited genetic factors that influence susceptibility to Non-Hodkin Lymphoma and other related Lymphoid Cancers within families.

Getty Images / Photographer: Marcy Maloy / RF

Healthy Aging (The Super-Seniors Study)

We study genetic factors that underlie healthy aging and resistance to age-related diseases such as cancer, cardiovascular and pulmonary disease, dementia and diabetes.

EZH2 ribbon model.

High Resolution Analysis of Follicular Lymphoma Genomes

High resolution analysis follicular lymphoma genomes to discover the genomic rearrangements contributing to development of follicular lymphoma and the additional rearrangements contributing to the progression from follicular lymphoma to diffuse large B cell lymphoma.

Atg4B and LC3 interacting.

Investigating Autophagy Proteins as Molecular Targets for Cancer Treatment

This team project aims to enhance the translation of promising autophagy-related discoveries and therapeutic strategies to treatments that are beneficial for patients with late stage and recurrent / treatment insensitive cancers.

Lymphoma Transcriptome Sequencing and Analysis

This project involves identifying and characterizing the range of mutations found in lymphoma tumours. Once identified, specific mutations may be shown to effect or be associated with response to treatment, patient outcome and survival, or be useful as a target for anti-cancer drug development.

MAGIC - Medulloblastoma Advanced Genomics International Consortium

Stratifying and Targeting Pediatric Medulloblastoma through Genomics

Mammalian Organogenesis (MORGEN)

Using the mouse as our model organism, we are identifying transcriptional networks of genes necessary for the development of the heart, lung, and pancreas.

Massively Parallel Sequencing of the human T-cell Receptor Repertoire

This is a comparative approach to understanding the individual variation in the human T-cell repertoires at the sequence level.

Mutation Specific Inhibitors in Breast Cancer Cell Lines

To use next generation sequencing technology to derive the complete genomic sequence of breast cancer cell lines.

Pleiades Promoter Project

To generate fully characterized, human DNA promoters of less than 4 kb (MiniPromoters) to drive gene expression in defined brain regions of therapeutic interest for diseases such as Alzheimer, Parkinson, Huntington, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Spinocerebellar Ataxia, Depression, Autism, and Cancer.

Potential Therapy for Prostate Cancer

Our aim is to design targeted therapies which will recognize and disable the androgen receptor when it is activated in the absence androgen.

Drosphila melanogaster close-up

Roles of macroautophagy in Drosophila development

The fruit fly is used as a model organism in which we study the process of autophagy at a cellular and whole organism level.

Single Cell Genomics

Integration of multilayer soft lithography with next-generation sequencing in order to achieve transcriptome analysis of single cells.

Children having fun in park from Getty Images.  Photographer: Vyacheslav Osokin. Copyright.

The Canadian Pediatric Cancer Genome Consortium (CPCGC)

Characterizing pediatric cancers through comprehensive genome review. Using the genetic information to find new therapies.

The Cancer Genome Atlas (TCGA)

Cancer transcriptome characterization using massively parallel DNA sequencing

The Lymphoid Cancer Families Study

The focus of this research is to discover the inherited genetic factors that influence susceptibility to Lymphoid Cancers (lymphoma, Hodgkin’s disease, multiple myeloma, and the lymphocytic leukemias) within families.

Rosettes of T-cells dividing in response to a peptide challenge.

Tumor infiltrating T cells in Ovarian Cancer

How does the immune system evolve during initial stages of ovarian cancer versus later recurrence of the disease? Our aim is to identify tumor antigens as unique targets for immuno-therapy in advanced ovarian cancer.


Personalized Oncogenomics

The BC Cancer Agency’s Personalized Oncogenomics program is a clinical research initiative that is embedding genomic sequencing into real-time treatment planning for BC patients with incurable cancers.


Completed Projects

Atlantic Salmon

Bioinformatics of Mammalian Gene Expression

Bovine Genome Sequencing

Canadian Molecular Cytogenetics Platform

Cancer Genomics

Expression Profiles of Cells and Tissues in C. elegans

Follicular Lymphoma as a Model of Cancer Progression

Functional Genomics of C. Neoformans

Genomic Tools for the Diagnosis and Evaluation of Mental Retardation

Genomics of Berry Quality in Grapevine (GrapeGen)

Identification and Cloning of deletions in C. elegans.

Mammalian Gene Collection - Closure (MGC)

Microbial Envirogenomics

Mouse Atlas

Role of Autophagy in the Therapeutic Response of Breast Cancer Cells

SARS Sequencing

Treenomix: Spruce, Poplar and Arabipdopsis